Previous close | 39.70 |
Open | 39.00 |
Bid | 39.50 |
Ask | 41.30 |
Strike | 260.00 |
Expiry date | 2026-01-16 |
Day's range | 38.80 - 39.70 |
Contract range | N/A |
Volume | |
Open interest | 299 |
Danaher Corporation (NYSE: DHR) (the "Company") confirmed its previously issued guidance for the third quarter and full year 2024 ahead of a previously scheduled analyst event.
We recently compiled a list of the 10 Best Cancer Stocks To Buy Now. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other cancer stocks. Global Oncology Market Overview and Drug Shortages In 2022, the global oncology market was valued at approximately $203.42 billion and is […]
HTHIY vs. DHR: Which Stock Is the Better Value Option?